Omanische Heilpflanze im Fokus der Phytochemie IPB-Wissenschaftler und Partner aus Dhofar haben jüngst die omanische Heilpflanze Terminalia dhofarica unter die phytochemische Lupe genommen. Die Pflanze ist reich an…
Geschmack ist vorhersagbar: Mit FlavorMiner. FlavorMiner heißt das Tool, das IPB-Chemiker und Partner aus Kolumbien jüngst entwickelt haben. Das Programm kann, basierend auf maschinellem Lernen (KI), anhand der…
Smolková, R.; Smolko, L.; Samoľová, E.; Morgan, I.; Rennert, R.; Kaluđerović, G. N.;Novel Zn(ii), Co(ii) and Cu(ii) diflunisalato complexes with neocuproine and their exceptional antiproliferative activity against cancer cell linesDalton Trans.5317595-17607(2024)DOI: 10.1039/d4dt01736f
Three novel complexes of deprotonated diflunisal (dif) with neocuproine (neo) were synthesized and characterized via elemental, spectral (UV-vis, FTIR, fluorescence, and mass spectrometry), and single-crystal X-ray diffraction analyses. Although the compounds shared a similar composition of [MCl(dif)(neo)], where M represents Zn(II) (1), Co(II) (2) and Cu(II) (3), only 1 and 2 were isostructural, while 3 differed in both the molecular and supramolecular structures. In all three complex molecules, the central atom is coordinated by two nitrogen atoms of neo in a bidentate chelate mode, and one chlorido ligand and dif is bonded in either a monodentate mode via one oxygen atom of the carboxylate in 1 and 2 or in a bidentate chelate mode via both carboxylate oxygen atoms in 3. All three compounds demonstrated remarkable antiproliferative activity against human prostate (PC-3), colon (HCT116) and breast (MDA-MB-468) cancer cell lines with IC50 values in the nanomolar range, with the lowest values observed in the case of PC-3 and MDA-MB-468 with 2 (20.0 nM) and 3 (31.1 nM), respectively. Moreover, complex 2, as the most active, was further investigated for its potential to induce perturbations in the cell cycle of PC-3 cells. The results indicated an induction of caspase-independent apoptosis. The interaction of the complexes with genomic DNA isolated from the respective cancer cell lines was evaluated for the intercalative mode, with binding strength correlated with the antiproliferative activity against PC-3 and MDA-MB-468 cancer cell lines.
Publikation
Predarska, I.; Saoud, M.; Morgan, I.; Eichhorn, T.; Kaluđerović, G. N.; Hey-Hawkins, E.;Cisplatin−cyclooxygenase inhibitor conjugates, free and immobilised in mesoporous silica SBA-15, prove highly potent against triple-negative MDA-MB-468 breast cancer cell lineDalton Trans.51857–869(2022)DOI: 10.1039/d1dt03265h
For the development of anticancer drugs with higher activity and reduced
toxicity, two approaches were combined: preparation of platinum(IV) complexes exhibiting higher stability compared to their platinum(II)
counterparts and loading them into mesoporous silica SBA-15 with the
aim to utilise the passive enhanced permeability and retention (EPR)
effect of nanoparticles for accumulation in tumour tissues. Three
conjugates based on a cisplatin scaffold bearing the anti-inflammatory
drugs naproxen, ibuprofen or flurbiprofen in the axial positions (1, 2 and 3, respectively) were synthesised and loaded into SBA-15 to afford the mesoporous silica nanoparticles (MSNs) SBA-15|1, SBA-15|2 and SBA-15|3.
Superior antiproliferative activity of both free and immobilised
conjugates in a panel of four breast cancer cell lines (MDA-MB-468,
HCC1937, MCF-7 and BT-474) with markedly increased cytotoxicity with
respect to cisplatin was demonstrated. All compounds exhibit highest
activity against the triple-negative cell line MDA-MB-468, with
conjugate 1 being the most potent. However, against MCF-7 and BT-474 cell lines, the most notable improvement was found, with IC50
values up to 240-fold lower than cisplatin. Flow cytometry assays
clearly show that all compounds induce apoptotic cell death elevating
the levels of both early and late apoptotic cells. Furthermore,
autophagy as well as formation of reactive oxygen species (ROS) and
nitric oxide (NO) were elevated to a similar or greater extent than with
cisplatin.
Publikation
de Moura, P. H. B.; de Sousa, A. A.; Porzel, A.; Wessjohann, L. A.; Leal, I. C. R.; Martins, R. C. C.;Characterization of antibacterial proanthocyanidins of Dalbergia monetaria, an amazonian medicinal plant, by UHPLC-HRMS/MSPlanta Med.86858– 866(2020)DOI: 10.1055/a-1170-8016
Dalbergia monetaria is an Amazonian plant whose bark is widely used to treat urinary tract infections. This paper describes a bio-guided study of ethanolic extracts from the bark and leaves of D. monetaria, in a search for metabolites active against human pathogenic bacteria. In vitro assays were performed against 10 bacterial strains, highlighting methicillin-sensitive Staphylococcus aureus and methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa. Fractioning of the extracts was performed using instrumental and classical techniques, and samples were characterized by UHPLC-HRMS/MS. Ethyl acetate fractions from bark and leaves showed similar antibacterial activities. EAFB is enriched in isoflavone C-glucosides and EAFL enriched in proanthocyanidins. Subfractions from EAFL presented higher activity and showed a complex profile of proanthocyanidins constructed by (epi)-cassiaflavan and (epi)-catechin units, including dimers, trimers and tetramers. The fragmentation pattern emphasized the neutral loss of cassiaflavan units by quinone-methide fission. Fraction SL7-6, constituted by (ent)-cassiaflavan-(ent)-cassiaflavan-(epi)-catechin isomers, showed the lowest MIC against the S. aureus and P. aeruginosa with values corresponding to 64 and 32 µg/mL, respectively. Cassiaflavan-proanthocyanidins have not been found previously in another botanical genus, except in Cassia, and the traditional medicinal use of D. monetaria might be related to the antibacterial activity of proanthocyanidins characterized in the species.
Publikation
Jouda, J.-B.; Njoya, E. M.; Fobofou, S. A. T.; Zhou, Z. Y.; Qiang, Z.; Mbazoa, C. D.; Brandt, W.; Zhang, G.-l.; Wandji, J.; Wang, F.;Natural Polyketides Isolated from the Endophytic Fungus
Phomopsis sp. CAM212 with a Semisynthetic Derivative Downregulating
the ERK/IκBα Signaling PathwaysPlanta Med.861032-1042(2020)DOI: 10.1055/a-1212-2930
AbstractThree previously undescribed natural products, phomopsinin A – C
(1 – 3), together with three known compounds, namely,
cis-hydroxymellein (4), phomoxanthone A (5) and
cytochalasin L-696,474 (6), were isolated from the solid culture of
Phomopsis sp. CAM212, an endophytic fungus obtained from Garcinia
xanthochymus. Their structures were determined on the basis of
spectroscopic data, including IR, NMR, and MS. The absolute configurations of
1 and 2 were assigned by comparing their experimental and
calculated ECD spectra. Acetylation of compound 1 yielded 1a, a
new natural product derivative that was tested together with other isolated
compounds on lipopolysaccharide-stimulated RAW 264.7 cells. Cytochalasin
L-696,474 (6) was found to significantly inhibit nitric oxide production,
but was highly cytotoxic to the treated cells, whereas compound 1
slightly inhibited nitric oxide production, which was not significantly
different compared to lipopolysaccharide-treated cells. Remarkably, the
acetylated derivative of 1, compound 1a, significantly inhibited
nitric oxide production with an IC50 value of 14.8 µM and no
cytotoxic effect on treated cells, thereby showing the importance of the acetyl
group in the anti-inflammatory activity of 1a. The study of the mechanism
of action revealed that 1a decreases the expression of inducible nitric
oxide synthase, cyclooxygenase 2, and proinflammatory cytokine IL-6 without an
effect on IL-1β expression. Moreover, it was found that 1a exerts
its anti-inflammatory activity in lipopolysaccharide-stimulated RAW 264.7
macrophage cells by downregulating the activation of ERK1/2 and by preventing
the translocation of nuclear factor κB. Thus, derivatives of phomopsinin
A (1), such as compound 1a, could provide new anti-inflammatory
leads.